Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sub-Inhibitory Concentrations of Florfenicol Modulate the Expression of Biofilm Formation and Antibiotic Resistance-Associated Genes in Biofilm-Embedded Piscirickettsia salmonis.

Journal of fish diseases·2026
Same author

Inventory and risk characterization of urban runoff pollutants in Europe.

Water research·2026
Same author

From Genetic Engineering to Preclinical Safety: A Study on Recombinant Human Interferons.

International journal of molecular sciences·2025
Same author

Accurate geometric albedo, shape, and size of Hi'iaka from a stellar occultation.

Nature communications·2025
Same author

Proteomic analysis of exosomes from <i>Brucella abortus</i>-infected macrophages reveals possible mechanisms of immune evasion and host modulation.

Frontiers in immunology·2025
Same author

Dietary Patterns and Sustainable Lifestyles: A Multicenter Study from Latin America and Spain.

Foods (Basel, Switzerland)·2025

Related Experiment Video

Updated: May 10, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.8K

In Silico Design and Characterization of a Multiepitope Vaccine Candidate Against Brucella canis Using a Reverse

Vicente Arriagada1, Alberto Osorio2, Crisleri Carrera-Naipil1

  • 1Laboratory of Molecular Immunology, Department of Microbiology, Faculty of Biological Sciences, University of Concepción, Concepción, Chile.

Journal of Immunology Research
|April 23, 2025
PubMed
Summary

A novel multiepitope vaccine candidate against Brucella canis was designed using reverse vaccinology. This computational approach identified key epitopes to elicit a strong immune response, offering a promising strategy for canine brucellosis prevention.

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.4K

Related Experiment Videos

Last Updated: May 10, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.8K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.4K

Area of Science:

  • Infectious Disease Immunology
  • Veterinary Vaccinology
  • Computational Biology

Background:

  • Brucella canis causes canine brucellosis, a zoonotic disease with significant public health and economic impacts.
  • Current control methods for canine brucellosis are limited, lacking effective preventive vaccines and facing diagnostic and transmission challenges.
  • Canine brucellosis prevalence varies, with higher rates in stray populations and under-resourced regions.

Purpose of the Study:

  • To design and characterize a novel multiepitope vaccine candidate against Brucella canis using a reverse vaccinology approach.
  • To identify and select immunogenic B-cell and T-cell epitopes from Brucella canis proteins.
  • To computationally evaluate the vaccine construct's properties, stability, and potential immunogenicity.

Main Methods:

  • In silico analysis of the Brucella canis proteome to identify potential vaccine target proteins.
  • Prediction and selection of highly immunogenic B-cell and T-cell epitopes based on specific criteria.
  • Assembly of selected epitopes into a multiepitope vaccine construct, followed by computational evaluation of its structure, antigenicity, and TLR4 binding affinity.

Main Results:

  • Four candidate proteins were identified, leading to the selection of six immunogenic epitopes.
  • The designed multiepitope vaccine construct demonstrated high antigenicity, non-allergenicity, and non-toxicity.
  • Molecular docking and dynamics simulations confirmed the vaccine's structural stability and high binding affinity to the TLR4 receptor.

Conclusions:

  • A computationally designed multiepitope vaccine candidate against Brucella canis shows promise for inducing robust humoral and cellular immune responses.
  • The developed vaccine construct is a potential candidate for conferring protective immunity against canine brucellosis.
  • The reverse vaccinology methodology employed can serve as a framework for developing vaccines against other pathogens.